Kathy Verble has over 15 years of experience in pharmaceutical sales, successfully launching and promoting various products. She has a proven track record of increasing market share and expanding key customer networks. Verble has received numerous awards for outstanding sales performance and currently works as a Pharmaceutical Sales Representative for Janssen Pharmaceuticals, where she mentors new hires and collaborates across teams.

1. KATHY VERBLE
10702 Eagle Glen Drive
Knoxville, Tennessee 37922
(865) 806-1940
kathy.verble@yahoo.com
CAREER SUMMARY
Offering diversified experience in pharmaceutical sales, territory management, customer
service, operations, project management and leadership. Successfully launched and
promoted a diversified portfolio of products to cardiology, endocrinology, surgery,
gastroenterology, rheumatology, OBGYN, primary care and internal medicine physicians
EMPLOYMENT
INVENTIV HEALTH for Janssen Pharmaceuticals Somerset, New Jersey
October 2015-Present, Pharmaceutical Sales Representative
Successfully promoted Xarelto and Invokana through sales and exceptional customer
service skills
 Xarelto Lead Representative
 Selected by manager to Southeast Region Xarelto Leadership Council
Resulted in expansion of Xarelto knowledge base, network with peers from all over
the Southeast and positive impact on territory, district and region
 Demonstrated collaboration by driving attendance and coordination with CVI Rep for
Xarelto Speaker Program
Resulted in 120 attendees
 Proactively developed efficient routing for Janssen Xarelto Lead new hire, including
scheduling of appointments and lunches, as well as Xarelto and Invokana speaker
programs for key offices
Resulted in expedited access for new hire, quick increase of share of voice and
resources to key offices
 Mentored new to pharma representative in territory
Resulted in increased territory management, access into key offices, resource
utilization, value based selling skills and administrative accuracy for new hire
 Collaborated with Janssen Xarelto Lead to identify cardiologists in territory not
covered by Janssen CVI rep
Result: Strategized to increase product utilization with these specialty providers, to
have a positive impact on primary care and internal medicine providers

2. VIVUS PHARMACEUTICALS Mountain View, California
2012-2015, Cardio-Metabolic Sales Specialist
Successfully launched Qsymia resulting in increased market share through sales and
excellent customer service skills to endocrinology, cardiology, surgery, OBGYN,
primary care, and internal medicine physicians
 District Trainer, District Diabetes Specialist, East Region Advisory Council Member
 2013 Growth and Big Mover Award
Given by Regional Director for Outstanding Performance
 2014 Century Club Award National award
100 or greater TRX weekly (1 of 2 in region)
 Led the region in Initiate Qsymia kit utilization by targeted physicians
Resulted in moving competitor writers to Qsymia writers
 Partnered with University Health Systems Chief Medical Officer on employee obesity
initiative resulting in bringing national speaker to University of Tennessee
: Resulted in development of relationship with Chief Medical Officer of the
University Health Systems at the University of Tenn Medical Center, Knoxville
: Resulted in a relationship with Key Opinion Leader and National Speaker, Dr. Scott
Kahan
: As a result I was able to bring Dr. Kahan, to the Medical Center to speak on obesity
to all employees of the hospital. That evening I utilized Dr. Kahan as a Qsymia
speaker at a program that evening for my targeted audience which, Dr. Lacey, Chief
Medical Officer of the University Health Systems attended as well as high decile
targets and physicians on the University of Tenn Medical Center P&T committee.
:This resulted in increased scripts as well as developed relationships with Vivus MSL
and NAM
 Chosen by management to pilot Qsymia Access Program and McKesson Tool
Resulted in both programs being rolled out to the field.
QAP has resulted in increased awareness of formulary coverage and therefore
increased scripts.
 Recognized for having a provider ranked third in the nation for utilization of Qsymia
Access Program.
: Recognized by DM, RM, and National Sales Director
 Recognized by DM and RM for utilization of Medical Science Liaison
MSL Utilization resulted in providers gaining comfort and confidence in prescribing
Qsymia, which increased sales.
 Selected by manager to represent Vivus at Product Booth Exhibits at state, regional
and national conferences
 Led multiple District Conference Calls promoting Best Practices, Corporate Tactics
and Territory Management Skills (monthly)
0) Increase synergy and positive energy
1) Best practices – how I rolled out IQ kit
2) Utilization of McKesson tool
3) Keep morale up: Be the voice of the patient
Resulted in synergy amongst the district, problem solving peer to peer

3. TAKEDA PHARMACEUTICALS NORTH AMERICA / TAP Lake Forest, Illinois
2001-2012, Pharmaceutical Sales Representative
Effectively increased market share through sales and customer service skills Promoted
and launched multiple products including Dexilant, Prevacid, Prevacid Naprapac, Uloric,
Amitiza, and Rozerem to primary care, internal medicine, pediatricians and specialty
target physicians.
 2010 Cresset Award Winner
Awarded annually to the top 15% reps who attained 100% to goal, all products
 Dexilant Team Lead with responsibility of coordinating speaker programs and
teleconferences.
Resulted in increased sales due to volume of providers participating
 Recognized by DM and RM for holding the most Amitiza Daytime Dialogue
Teleconferences and most teleconference participants in the district.
Resulted in increased sales and increased value brought to providers
 Recognized by DM, RM and National Sales Director for being among the top 15
sales representatives in the region for generating highest market share for nurse
practitioners and physician assistants Recognized for top resource utilization.
VENTIV HEALTH, U.S. SALES, Somerset, New Jersey
1998-2000 Pharmaceutical Sales Representative, Bristol-Myers Squibb Company.
Effectively increased market share of Monopril, Cefzil, and Buspar through sales and
customer service skills calling on cardiology, primary care, internal medicine, and
pediatric physicians
 Increased Monopril market share by 41%
: 41% increase was due to strategic planning, territory management, customer service
skill, and proper sample placement
 Recognized nationally for Cefzil contest, change in volume over base
Ranked 6
During college I started my own business: A performing arts studio and retail dance
apparel space inside the studio.
This resulted in owning and operating a business.
The importance of appropriate marketing, pricing, administrative details
The importance of growing the brand
Maintaining a positive work environment with employees and customers
Motivating others
Developing synergy among peers
OTHER ACCOMPLISHMENTS
VOLUNTEER EDUCATION
Relay For Life University of Tennessee, B.S.
Hope for Haiti
American Diabetes Association